Revvity, Inc.

NYSE:RVTY

Medical - Diagnostics & Research

Healthcare
$152.43 -3.36%

-$3.40 today

Market cap
$17.02B
Beta
1.11
P/E (TTM)
45.4
EPS (TTM)
$2.15
Dividend yield
0.29%
52W Low $81.22High $118.30

Volume 1.09M

Average 1.27M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

$581.78M

FY 2025 · Annual

-7.4% YoY

Investing Cash Flow

-$17.35M

FY 2025 · Annual

Financing Cash Flow

-$855.05M

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income889.44M512.68M179.5M283.07M241.2M
Depreciation & Amortization311.44M427M431.77M427.85M405.34M
Deferred Income Tax(53.4M)(107.41M)(97.48M)(110.31M)(61.48M)
Stock-Based Compensation29.68M51.52M41.41M37.81M22.85M
Change in Working Capital132.99M(262.97M)(391.35M)(18.31M)(96.78M)
Accounts Receivables165.59M66.09M(9M)(15.97M)(101.02M)
Inventory32.28M(48.63M)(14.11M)45.09M14.78M
Accounts Payables(7.58M)(43.8M)(76.43M)(26.03M)7.35M
Other Working Capital(57.3M)(236.62M)(291.81M)(21.4M)(17.89M)
Other Non-Cash Items100.61M59M(72.58M)8.18M70.65M
Operating Cash Flow1.41B679.81M91.27M628.3M581.78M
Capital Expenditures(86.02M)(85.63M)(81.37M)(86.65M)(73.52M)
Acquisitions (Net)(3.98B)6.99M(1.93M)00
Purchases of Investments(23.13M)(47.18M)(1.23B)(6.59M)(385K)
Sales of Investments08.89M550M712.5M0
Other Investing Activities(22.96M)(15.92M)2.07B156.9M56.55M
Investing Cash Flow(4.11B)(132.85M)1.31B776.16M(17.35M)
Debt Repayment3.04B(559.17M)(517.49M)(723.07M)(521K)
Common Stock Issued25.12M14.11M002.93M
Common Stock Repurchased(73.07M)(80.64M)(388.88M)(369.58M)(820.82M)
Dividends Paid(32.37M)(35.34M)(34.97M)(34.45M)(32.8M)
Other Financing Activities(21M)(767K)(5.79M)(1.13M)(3.84M)
Financing Cash Flow2.94B(661.8M)(947.12M)(1.13B)(855.05M)
Effect of Forex Changes(22.93M)(33.75M)(14.05M)(26.15M)46.04M
Net Change in Cash216.72M(148.59M)443.63M250.08M(244.59M)
Free Cash Flow1.32B594.18M9.9M541.65M508.26M

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income$241.2M
+ D&A$405.3M
+ Stock-Based Comp$22.8M
- Deferred Tax-$61.5M
- Working Capital-$96.8M
+ Other Non-Cash$70.7M
= Operating Cash Flow$581.8M
- Capex-$73.5M
= Free Cash Flow$508.3M

Analysis

FY2025 free cash flow is $508.3M. FCF conversion is 210.7% of net income. Operating cash flow was $581.8M, with capex of -$73.5M. The largest bridge item is D&A at $405.3M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 13, 2026
10-QQuarterly reportNov 10, 2026
8-KCurrent reportNov 3, 2026
SC 13G/ASC 13G/A filingOct 7, 2026
4Statement of changes in beneficial ownershipOct 2, 2026

Does RVTY generate free cash flow?

Revvity, Inc. (RVTY) generated $508.25M of free cash flow in fiscal 2025.

How much operating cash flow does RVTY produce?

Operating cash flow was $581.78M, before capital expenditures of $73.52M.